Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Cirrus Logic, Inc. today announced the appointment of Jeff Woolard as chief financial officer, effective February 24, 2025. Jeff has more than 30 years of experience in the technology industry with ...

EDMONTON – Alberta’s government says it has dismantled the board of Alberta Health Services — for the second time in nearly as many years — and appointed a high-ranking bureaucrat as ...

U.N. officials vowed Thursday that the agency would continue to deliver services in the Palestinian territories for as long as possible.

Baxter International Inc. (BAX), a healthcare company, Monday announced the appointment of Lead Independent Director Brent Shafer as ...

The Board of Directors of Hammond-Henry Hospital in Geneseo have announced the appointment of a new Interim CEO Bradley ...

Aster DM Healthcare reported a strong financial performance for the third quarter (Q3) and nine months (9M) of FY25, driven ...

Profit rose in the fourth quarter compared to the same period of the previous year for French banking giant BNP Paribas. BNP ...

President Donald Trump on Tuesday proposed moving Gazans to a “good, fresh, beautiful piece of land” in another country, ...

The transition of the Company’s ordinary shares to the OTC Expert Market is not expected to affect the Company’s business operations or its reporting requirements under the rules of the Securities and ...

The latest change in AHS leadership comes as the Smith government continues to diminish the singular role the agency has long had in managing health care of ... officer and an interim vice ...